214 related articles for article (PubMed ID: 1601029)
1. Murine epidermal Langerhans cells are potent stimulators of an antigen-specific T cell response to Leishmania major, the cause of cutaneous leishmaniasis.
Will A; Blank C; Röllinghoff M; Moll H
Eur J Immunol; 1992 Jun; 22(6):1341-7. PubMed ID: 1601029
[TBL] [Abstract][Full Text] [Related]
2. Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen-specific T cells.
Moll H; Fuchs H; Blank C; Röllinghoff M
Eur J Immunol; 1993 Jul; 23(7):1595-601. PubMed ID: 8325337
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response.
Moll H; Flohé S; Röllinghoff M
Eur J Immunol; 1995 Mar; 25(3):693-9. PubMed ID: 7705398
[TBL] [Abstract][Full Text] [Related]
4. CD8 alpha- and Langerin-negative dendritic cells, but not Langerhans cells, act as principal antigen-presenting cells in leishmaniasis.
Ritter U; Meissner A; Scheidig C; Körner H
Eur J Immunol; 2004 Jun; 34(6):1542-50. PubMed ID: 15162423
[TBL] [Abstract][Full Text] [Related]
5. Molecular cloning of a novel protein antigen of Leishmania major that elicits a potent immune response in experimental murine leishmaniasis.
Webb JR; Kaufmann D; Campos-Neto A; Reed SG
J Immunol; 1996 Dec; 157(11):5034-41. PubMed ID: 8943412
[TBL] [Abstract][Full Text] [Related]
6. Leishmania antigens presented by GM-CSF-derived macrophages protect susceptible mice against challenge with Leishmania major.
Doherty TM; Coffman RL
J Immunol; 1993 Jun; 150(12):5476-83. PubMed ID: 8515072
[TBL] [Abstract][Full Text] [Related]
7. Distinct immunological states in murine cutaneous leishmaniasis by immunising with different amounts of antigen: the generation of beneficial, potentially harmful, harmful and potentially extremely harmful states.
Bretscher PA; Ogunremi O; Menon JN
Behring Inst Mitt; 1997 Feb; (98):153-9. PubMed ID: 9382736
[TBL] [Abstract][Full Text] [Related]
8. The mechanism of in vitro T helper cell type 1 to T helper cell type 2 switching in highly polarized Leishmania major-specific T cell populations.
Mocci S; Coffman RL
J Immunol; 1997 Feb; 158(4):1559-64. PubMed ID: 9029090
[TBL] [Abstract][Full Text] [Related]
9. The role of chemokines and accessory cells in the immunoregulation of cutaneous leishmaniasis.
Moll H
Behring Inst Mitt; 1997 Mar; (99):73-8. PubMed ID: 9303204
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of tolerance.
Enk AH; Angeloni VL; Udey MC; Katz SI
J Immunol; 1993 Sep; 151(5):2390-8. PubMed ID: 8103065
[TBL] [Abstract][Full Text] [Related]
11. T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure.
Coutinho SG; Oliveira MP; Da-Cruz AM; De Luca PM; Mendonça SC; Bertho AL; Soong L; McMahon-Pratt D
Exp Parasitol; 1996 Nov; 84(2):144-55. PubMed ID: 8932764
[TBL] [Abstract][Full Text] [Related]
12. Early production of IL-4 and induction of Th2 responses in the lymph node originate from an MHC class I-independent CD4+NK1.1- T cell population.
von der Weid T; Beebe AM; Roopenian DC; Coffman RL
J Immunol; 1996 Nov; 157(10):4421-7. PubMed ID: 8906817
[TBL] [Abstract][Full Text] [Related]
13. Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells.
Sadick MD; Heinzel FP; Shigekane VM; Fisher WL; Locksley RM
J Immunol; 1987 Aug; 139(4):1303-9. PubMed ID: 3112230
[TBL] [Abstract][Full Text] [Related]
14. LeIF: a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile.
Skeiky YA; Kennedy M; Kaufman D; Borges MM; Guderian JA; Scholler JK; Ovendale PJ; Picha KS; Morrissey PJ; Grabstein KH; Campos-Neto A; Reed SG
J Immunol; 1998 Dec; 161(11):6171-9. PubMed ID: 9834103
[TBL] [Abstract][Full Text] [Related]
15. Fresh and cultured Langerhans cells display differential capacities to activate hapten-specific T cells.
Dai R; Grammer SF; Streilein JW
J Immunol; 1993 Jan; 150(1):59-66. PubMed ID: 8417131
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of epidermal Langerhans cell function by low dose ultraviolet B radiation. Ultraviolet B radiation selectively modulates ICAM-1 (CD54) expression by murine Langerhans cells.
Tang A; Udey MC
J Immunol; 1991 May; 146(10):3347-55. PubMed ID: 1673983
[TBL] [Abstract][Full Text] [Related]
17. T-cell responses to immunodominant LACK antigen do not play a critical role in determining susceptibility of BALB/c mice to Leishmania mexicana.
Torrentera FA; Glaichenhaus N; Laman JD; Carlier Y
Infect Immun; 2001 Jan; 69(1):617-21. PubMed ID: 11119565
[TBL] [Abstract][Full Text] [Related]
18. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis.
Scharton-Kersten T; Afonso LC; Wysocka M; Trinchieri G; Scott P
J Immunol; 1995 May; 154(10):5320-30. PubMed ID: 7730635
[TBL] [Abstract][Full Text] [Related]
19. In vitro evidence that Langerhans cells can adopt two functionally distinct forms capable of antigen presentation to T lymphocytes.
Streilein JW; Grammer SF
J Immunol; 1989 Dec; 143(12):3925-33. PubMed ID: 2592763
[TBL] [Abstract][Full Text] [Related]
20. Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniosis.
Iborra S; Soto M; Carrión J; Alonso C; Requena JM
Vaccine; 2004 Sep; 22(29-30):3865-76. PubMed ID: 15364433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
